Rankings
▼
Calendar
PRAX Q3 2019 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
$6B
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$11M
Net Income
-$11M
EPS (Diluted)
$-101.99
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$8M
Stock-Based Comp.
$276,000
← FY 2019
All Quarters
Q4 2019 →